Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Alnylam
Welcome,
Profile
Billing
Logout
28 Products
7 Diseases
28 Products
88 Trials
5030 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Leqvio
(inclisiran) / Novartis
Veopoz
(pozelimab-bbfg) / Regeneron
elebsiran
(VIR-2218) / Alnylam, Vir Biotech
cemdisiran
(ALN-CC5) / Alnylam, Regeneron
Onpattro
(patisiran) / Alnylam, Sanofi
Oxlumo
(lumasiran) / Alnylam
Qfitlia
(fitusiran) / Sanofi
Rivfloza
(nedosiran) / Novo Nordisk
zilebesiran
(ALN-AGT) / Alnylam, Roche
revusiran
(ALN-TTRsc) / Alnylam, Sanofi
Amvuttra
(vutrisiran) / Alnylam
Givlaari
(givosiran) / Alnylam
belcesiran
(NN6021) / Alnylam
ALN-PNP
/ Alnylam, Regeneron
mivelsiran
(ALN-APP) / Alnylam
rapirosiran
(ALN-HSD) / Regeneron
ALN-AAT
/ Alnylam
ALN-AAT02
/ Alnylam, Novo Nordisk
ALN-HTT
/ Regeneron, Alnylam
ALN-KHK
/ Alnylam
ALN-PCS01
/ Novartis
ALN-SOD
/ Alnylam, Regeneron
ALN-XDH
/ Alnylam
nucresiran
(ALN-TTRsc04) / Alnylam
